Profil
Gitte L.
Pedersen founded Genomic Expression, Inc. in 2012, where she is working as Chief Executive Officer & Director from 2012.
Ms. Pedersen also currently works at ExpreS2ion Biotechnologies ApS, as Independent Director.
Ms. Pedersen also formerly worked at Expres2ion Biotech Holding AB, as Director and Novo Nordisk A, as Head-Marketing from 1987 to 1997.
Ms. Pedersen received her graduate degree from Technical University of Denmark.
Postes actifs de Gitte Pedersen
| Sociétés | Poste | Début |
|---|---|---|
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Directeur/Membre du Conseil | - |
Genomic Expression, Inc.
Genomic Expression, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of ribonucleic acid product for cancer treatment | Fondateur | 01/08/2012 |
Anciens postes connus de Gitte Pedersen
| Sociétés | Poste | Fin |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Directeur/Membre du Conseil | 26/05/2021 |
| NOVO NORDISK A/S | Sales & Marketing | 01/06/1997 |
Formation de Gitte Pedersen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Genomic Expression, Inc.
Genomic Expression, Inc. Pharmaceuticals: MajorHealth Technology Engages in development of ribonucleic acid product for cancer treatment | Health Technology |
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Health Technology |
Expres2ion Biotech Holding AB
Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
















